U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882732) titled 'RPM Signals in Outpatient CAR T Therapy' on Sept. 29.
Brief Summary: The goal of this observational study is to learn how patients' vital signs and symptoms change during outpatient CAR T-cell therapy with lisocabtagene maraleucel (liso-cel), a type of cancer treatment. The study tracks vital signs and other health data at home using wearable monitoring devices. It includes adults with blood cancers who are receiving liso-cel as outpatients, meaning they are at home rather than staying in the hospital during treatment.
The main questions it aims to answer are:
* What do patients' vital signs and monitoring data look like from 3 da...